Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
doctorate or other terminal degree in the relevant field of study or possession of equivalent experience. The Director of the Sustainability Institute at Ohio State is responsible for providing
-
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
Senior Analyst - Institute of Brain, Behavior, and Immunology Department: Medicine | Psychiatry Functions as Business Operations Senior Analyst in Administration for the Institute of Brain, Behavior
-
OSU | about 2 months ago
College, and its long-term institutional performance. The Assistant Dean provides vision, strategic direction and collaborative leadership for student success–related programming, including initiatives
-
OSU | about 1 month ago
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
OSU | about 1 month ago
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
OSU | about 1 month ago
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
OSU | about 2 months ago
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
science problems are especially encouraged to apply. The successful candidate will contribute to the development of next-generation AI methods for geophysical imaging and monitoring, advancing both
-
OSU | about 1 month ago
-Comprehensive Cancer Center Department: CCC | Sponsored Research Scope/Summary: The Researcher 1 will support the Center for Antibody Therapeutics (CAT) within the Pelotonia Institute for Immuno-Oncology (PIIO